216 related articles for article (PubMed ID: 21525003)
21. From molecular details of the interplay between transmembrane helices of the thyrotropin receptor to general aspects of signal transduction in family a G-protein-coupled receptors (GPCRs).
Kleinau G; Hoyer I; Kreuchwig A; Haas AK; Rutz C; Furkert J; Worth CL; Krause G; Schülein R
J Biol Chem; 2011 Jul; 286(29):25859-71. PubMed ID: 21586576
[TBL] [Abstract][Full Text] [Related]
22. Influence of the hinge region and its adjacent domains on binding and signaling patterns of the thyrotropin and follitropin receptor.
Schaarschmidt J; Huth S; Meier R; Paschke R; Jaeschke H
PLoS One; 2014; 9(10):e111570. PubMed ID: 25340405
[TBL] [Abstract][Full Text] [Related]
23. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions.
Núñez Miguel R; Sanders J; Chirgadze DY; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2009 May; 42(5):381-95. PubMed ID: 19221175
[TBL] [Abstract][Full Text] [Related]
24. The thyrotropin receptor hinge region as a surrogate ligand: identification of loci contributing to the coupling of thyrotropin binding and receptor activation.
Chen CR; Salazar LM; McLachlan SM; Rapoport B
Endocrinology; 2012 Oct; 153(10):5058-67. PubMed ID: 23002040
[TBL] [Abstract][Full Text] [Related]
25. Proper targeting and activity of a nonfunctioning thyroid-stimulating hormone receptor (TSHr) combining an inactivating and activating TSHr mutation in one receptor.
Agretti P; De Marco G; Collecchi P; Chiovato L; Vitti P; Pinchera A; Tonacchera M
Eur J Biochem; 2003 Sep; 270(18):3839-47. PubMed ID: 12950268
[TBL] [Abstract][Full Text] [Related]
26. New pathogenic thyrotropin receptor mutations decipher differentiated activity switching at a conserved helix 6 motif of family A GPCR.
Biebermann H; Winkler F; Handke D; Teichmann A; Gerling B; Cameron F; Eichhorst J; Grüters A; Wiesner B; Kühnen P; Krude H; Kleinau G
J Clin Endocrinol Metab; 2012 Feb; 97(2):E228-32. PubMed ID: 22112806
[TBL] [Abstract][Full Text] [Related]
27. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
Kosugi S; Ban T; Kohn LD
Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
[TBL] [Abstract][Full Text] [Related]
28. Structure-function relationships of two loss-of-function mutations of the thyrotropin receptor gene.
Costagliola S; Sunthorntepvarakul T; Migeotte I; Van Sande J; Kajava AM; Refetoff S; Vassart G
Thyroid; 1999 Oct; 9(10):995-1000. PubMed ID: 10560953
[TBL] [Abstract][Full Text] [Related]
29. A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain.
Chen CR; McLachlan SM; Rapoport B
Endocrinology; 2009 Jul; 150(7):3401-8. PubMed ID: 19299457
[TBL] [Abstract][Full Text] [Related]
30. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design.
Zhang M; Tong KP; Fremont V; Chen J; Narayan P; Puett D; Weintraub BD; Szkudlinski MW
Endocrinology; 2000 Sep; 141(9):3514-7. PubMed ID: 10965926
[TBL] [Abstract][Full Text] [Related]
31. Targeted restoration of cleavage in a noncleaving thyrotropin receptor demonstrates that cleavage is insufficient to enhance ligand-independent activity.
Chen CR; Chazenbalk GD; McLachlan SM; Rapoport B
Endocrinology; 2003 Apr; 144(4):1324-30. PubMed ID: 12639915
[TBL] [Abstract][Full Text] [Related]
32. Differential responses of an invariant region in the ectodomain of three glycoprotein hormone receptors to mutagenesis and assay conditions.
Angelova K; Puett D
Endocrine; 2002 Nov; 19(2):147-54. PubMed ID: 12588044
[TBL] [Abstract][Full Text] [Related]
33. The third exoplasmic loop of the thyrotropin receptor is partially involved in signal transduction.
Kosugi S; Mori T
FEBS Lett; 1994 Jul; 349(1):89-92. PubMed ID: 8045308
[TBL] [Abstract][Full Text] [Related]
34. Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties.
Chen CR; McLachlan SM; Rapoport B
Endocrinology; 2008 Jul; 149(7):3427-34. PubMed ID: 18388191
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of a Frameshift TSH Receptor Variant Val711Phefs*18 is Due to Acquisition of a Hydrophobic Degron.
Sugisawa C; Ono M; Kashimada K; Hasegawa T; Narumi S
J Clin Endocrinol Metab; 2021 Jan; 106(1):e265-e272. PubMed ID: 33108452
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody.
Sanders P; Young S; Sanders J; Kabelis K; Baker S; Sullivan A; Evans M; Clark J; Wilmot J; Hu X; Roberts E; Powell M; Núñez Miguel R; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2011 Apr; 46(2):81-99. PubMed ID: 21247981
[TBL] [Abstract][Full Text] [Related]
37. The intracellular region adjacent to plasma membrane (residues 684-692) of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
Kosugi S; Mori T
Biochem Biophys Res Commun; 1994 Mar; 199(3):1497-503. PubMed ID: 8147896
[TBL] [Abstract][Full Text] [Related]
38. [Peptide 612-627 of thyrotropin receptor and its modified derivatives as the regulators of adenylyl cyclase in the rat thyroid gland].
Shpakov AO; Shpakova EA; Tarasenko II; Derkach KV
Tsitologiia; 2014; 56(7):526-35. PubMed ID: 25696997
[TBL] [Abstract][Full Text] [Related]
39. Computational model of the full-length TSH receptor.
Mezei M; Latif R; Davies TF
Elife; 2022 Oct; 11():. PubMed ID: 36305581
[TBL] [Abstract][Full Text] [Related]
40. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
